# Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation

Study · id `cardio:ct-nct01994252` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01994252](<https://clinicaltrials.gov/study/NCT01994252>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01994252

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 200 participants.

## Technical summary

Registry record NCT01994252. Randomized; quadruple masking; primary purpose treatment. Start 2014-06-04 (actual); primary completion 2024-01-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT01994252, source copy `cardio:ctgov-nct01994252-2026-04-30`, retrieved 2026-10-26)
- Started: 2014-06-04 (actual) (ClinicalTrials.gov record NCT01994252, source copy `cardio:ctgov-nct01994252-2026-04-30`, retrieved 2026-10-26)
- Primary completion: 2024-01-31 (actual) (ClinicalTrials.gov record NCT01994252, source copy `cardio:ctgov-nct01994252-2026-04-30`, retrieved 2026-10-26)
- Completion: 2025-05-29 (actual) (ClinicalTrials.gov record NCT01994252, source copy `cardio:ctgov-nct01994252-2026-04-30`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01994252, source copy `cardio:ctgov-nct01994252-2026-04-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01994252-2026-04-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
- Acronym: RAFT-PermAF
- Condition: Heart Disease
- Condition: Congestive Heart Failure
- Condition: Atrial Fibrillation
- Intervention (Device): Optimal Medical therapy plus ICD
- Intervention (Device): Optimal Medical therapy plus CRT/ICD
- Lead sponsor: Ottawa Heart Institute Research Corporation
- Lead sponsor class: OTHER
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Ottawa Heart Institute Research Corporation (`cardio:org-ottawa-heart-institute-research-corporation`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)

## Provenance

Content hash: 740c0ab4362f2042cf585049b58bb933629ddf11d777eca0094a4621c0ed670e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
